Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Konstanz – page 2

20 clinical trials in Konstanz, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Konstanz at a glance
20
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

20 trials in Konstanz

Open in trial search
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1819479
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Axatilimab
  • Sponsor:Syndax Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Afatinib
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd2693 Sodium
  • Sponsor:AstraZeneca AB

Bronchiectasis

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Konstanz

What the registry says about research in the country

01 Pulmonary Research

Innovative trials focusing on pulmonary fibrosis and related conditions, including studies of new therapeutic agents for idiopathic pulmonary fibrosis and progressive lung diseases.

  • Lung function improvement studies
  • Fibrosis treatment evaluation
  • Bronchiectasis management

Research includes long-term safety assessments and evaluation of novel compounds for respiratory conditions.

02 Oncology Studies

Comprehensive research into various cancer types, with particular focus on ovarian cancer and breast cancer treatments, including innovative combination therapies.

  • Advanced breast cancer treatments
  • Hepatocellular carcinoma therapy
  • Leukemia treatment protocols

Studies evaluate maintenance therapies and novel drug combinations for improved patient outcomes.

03 Metabolic Disorders

Clinical investigations targeting liver diseases and metabolic conditions, including studies on non-alcoholic steatohepatitis and cholesterol management.

  • Liver fibrosis treatments
  • Cholesterol reduction therapies
  • Genetic marker studies

Research focuses on innovative treatments for metabolic disorders and their complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.